TAVR for intermediate risk patients?

Tanscatheter aortic valve replacement may be the best option for intermediate risk patients with severe aortic stenosis, say researchers, but an expert has reservations.

The US and Canadian study, presented at ACC16 and published in the Lancet, looked at outcomes in 963 intermediate risk patients, enrolled in the SAPIEN3 observational study, one year after they had TAVR.   

Commenting in the Lancet,

Latest

Trending